FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 3, 2005
Meditech Pharmaceuticals Inc.
---------------------------------------
(Exact name of registrant as specified in its charter)
Nevada 000-12561 95-3819300
- ------------------------ --------------------- -------------------
(State of Incorporation) (Commission File No.) (IRS Employer
Identification No.)
558 Lime Rock Road, Lime Rock, Connecticut 06039
(Address of principal execute offices, including zip code)
(860)435-7000
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[_] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
ITEM 9.01 Financial Statements and Exhibits
---------------------------------
(c) Exhibits Name of Exhibit
-------- ---------------
99.1 Press release of Registrant dated
August 3,2005.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: August 3, 2005 Meditech Pharmaceuticals, Inc.
(Registrant)
By: /s/ Deli Du
------------------------------------
Deli Du
President and Chief Executive Officer
